February 9 2023
News
January 27 2023
Start-up LinKinVax and Gustave Roussy enter into a collaboration to conduct a Phase I/IIa HPV.DCVax clinical trial for the treatment of patients with human papillomavirus (HPV) associated oropharyngeal cancer
January 3 2023
Congratulations to Pr. Josselin Houenou, Marion Leboyer’s team, winner of the Matmut Prize for Medical Innovation 2022
November 28 2022
AAP of the ARC Foundation “Cancer and Aging”: Congratulations to Serge Adnot, from the team of G. Derumeaux, biological coordinator of the project, and Florence Canouï-Poitrine and Christos Chouaid from the team S. Bastuji-Garin, team associated with the project: “Identification of biomarkers of aging to better adapt the treatment of bronchial cancers in elderly subjects. A clinico-biological approach in 2 steps”, which has just been selected by the ARC Foundation
July 11 2022
Visiting IMRB for her first official visit, Mrs. Sylvie RETAILLEAU, Minister of Higher Education and Research did not come empty-handed!
July 4 2022
Congratulations to Laura Fertitta from the Mondor Neurofibromatosis Reference Center, Pierre Wolkenstein, CRN Mondor and IMRB-Gaulard team, and Piotr Topilko, IMRB-Gaulard team, who have just successfully applied to the prestigious Francis S. Collins Scholarship program at John Hopkins University!
April 25 2022
Congratulations to Maëlle BRIOTTET, doctoral student in Sophie Lanone’s team in Valérie Urbach’s group, who received the Prize of the association Vaincre la Mucoviscidose during the French Symposium for Young Researchers
April 19 2022
Omicron variant: Vaccination reveals a strong but incomplete immune escape. A study signed by Matthieu Mahévas’ group within the France Pirenne team and published this month in Immunity
April 8 2022
A new treatment for post-transplant leukemia relapse! A study by José Cohen’s I-BIOT team published this month in the Journal for Immunotherapy of cancer
March 1 2022
The DIM One Health 2.0 project led by Inserm and Prof. Jean-Daniel Lelièvre, accredited by the Ile-de-France region
February 21 2022
Artificial intelligence predicts immune and inflammatory genetic signatures directly from hepatocellular carcinoma histology. A study led by Prof. Julien Calderaro and published in Journal of Hepatology
February 7 2022
The FRM labels Bijan Ghaleh’s team for its project “The heme as a danger molecule during myocardial infarction”.
January 31 2022
Publication in Nature Medicine of the long-term results of the HGB-205 gene therapy trial for beta-hemoglobinopathies, conducted at the Necker Hospital and for which the analyses of patients with sickle cell disease were carried out by the France Pirenne team (N. Hebert, L. Kiger, P. Bartolucci).
January 24 2022
Publication in Lancet of the results of the SEPREVEN* study: randomized trial conducted in 12 neonatal intensive care units in France with the theme of patient safety.
January 5 2022
Publication in the Journal of the American College of Cardiology (IF 24.09) of a study on the identification of typical clinical profiles in patients with suspected cardiac amyloidosis
December 18 2021
